Abbott Laboratories (ABT) stock
Last close $103.87 on 2026-11-19 (-0.58%) · Sector: Healthcare
Abbott Laboratories is a large American healthcare company that makes medical devices, diagnostic tests, and nutrition and medical products. It earns money mainly by selling these products to hospitals, doctors, labs, and everyday customers around the world.
Abbott's revenue is growing, with trailing 12-month revenue of $48.2 billion and 10.0% growth, but profit margins have narrowed in recent quarters. The stock is down 16.2% over the past year while the S&P 500 rose 9.7%, so it has lagged the broader market. Insiders sold about $46.6 million of stock in the last 90 days and bought none, and the stock has risen after only 1 of its last 4 earnings reports.
Key numbers
- Market cap: $180.5B
- Revenue (last 12 months): $48.22B
- Revenue growth: +10.0%
- Gross margin: 56.9%
- Operating margin: 13.8%
- P/E: 38.8
- P/S: 3.7
- Debt to equity: 0.58
- Current ratio: 1.46
Quality score
Overall 31/100 · growth 38 · profitability 37 · financial health 48 · value 0
Performance and risk
1-year return -16.2% vs S&P 500 +9.7% · volatility 28.4% (S&P 500 13.8%) · largest drop -36.0% · beta 0.09
Stock move the day after earnings
- 2026-01-22: -10.0%
- 2026-04-16: -6.0%
- 2026-07-16: +10.7%
- 2026-10-21: -1.9%
Congress trades (90 days)
1 buys, 2 sells
Insider trades (12 months)
Bought $4.4M · sold $47.9M
ABT stock research · ABT options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.